Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/2142 stock hub

HKG/2142 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2142is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

11B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2142

In the news

Latest news · HKG/2142

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E24.1

P25 11.7P50 18.9P75 41.4

Trailing P/E15.4

P25 10.7P50 17.9P75 38.5

ROE37.6

P25 -14.7P50 2P75 9.4

ROIC173.4

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2142 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

216

Groups with data

Currency

USD

Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	210
Employees Change	27%
Employees Change Percent	14.75
Enterprise value	HKD 8.5B
Exchange	Hong Kong Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE1000005P7
Last refreshed	2026-05-10
Market cap	HKD 11B
Price	HKD 13.2
Price currency	HKD
Rev Per Employee	4,520,547.55x
Sector	Healthcare
Sic	2836
Symbol	hkg/2142
Website	https://www.harbourbiomed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.45%
EV Earnings	12x
EV/EBIT	13.61x
EV/EBITDA	13.21x
EV/FCF	14.22x
EV/Sales	6.94x
FCF yield	5.44%
Forward P/E	24.09x
P/B ratio	3.86x
P/E ratio	15.42x
P/S ratio	8.97x
PE Ratio3 Y	23.86x
PE Ratio5 Y	18.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	51.01%
EBITDA Margin	51.65%
FCF margin	48.78%
Gross margin	94.47%
Gross Profit	HKD 1.2B
Gross Profit Growth	38.76%
Gross Profit Growth Q	375.62%
Gross Profit Growth3 Y	29.32%
Gross Profit Growth5 Y	22.57%
Net Income	HKD 710.9M
Net Income Growth	3,187.73%
Net Income Growth Q	1,348.67%
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Net Income Growth3 Y	62.46%
Pretax Margin	59.21%
Profit Margin	57.81%
Profit Per Employee	HKD 2.6M
Profitable Years	3
ROA	14.08
Roa5y	-7.46
ROCE	19.46
ROE	37.55
Roe5y	-14.6
ROIC	173.4
Roic5y	-256.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	61.42%
Cagr3y	89.46%
Cagr5y	5.63%
EPS Growth	2,958.9
EPS Growth Q	1,132.2
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth3 Y	56.55
FCF Growth	152.67%
FCF Growth3 Y	56.41%
OCF Growth	165.14%
OCF Growth3 Y	56.84%
Revenue Growth	314.63x
Revenue Growth Q	293.5x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	29.82x
Revenue Growth5 Y	23.94x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.44
Assets	HKD 3.9B
Cash	HKD 3.1B
Current Assets	HKD 3.5B
Current Liabilities	HKD 675.1M
Debt	HKD 636.4M
Debt EBITDA	HKD 0.98
Debt Equity	HKD 0.22
Debt FCF	HKD 1.06
Equity	HKD 2.9B
Interest Coverage	39.48
Liabilities	HKD 1B
Long Term Assets	HKD 401.9M
Long Term Liabilities	HKD 361.2M
Net Cash	HKD 2.5B
Net Cash By Market Cap	HKD 22.67
Net Cash Growth	203.44%
Net Debt EBITDA	HKD -3.94
Net Debt Equity	HKD -0.88
Net Debt FCF	HKD -4.17
Tangible Book Value	HKD 2.8B
Tangible Book Value Per Share	HKD 3.35
WACC	11.43

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.17
Inventory Turnover	1.99
Net Working Capital	HKD 114.6M
Quick ratio	4.74
Working Capital	HKD 2.8B
Working Capital Turnover	HKD 5.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.95%
Payout Ratio	0.39%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	61.37%
200-day SMA	12.93
3Y total return	580.41%
50-day SMA	12.92
50-day SMA vs 200-day SMA	50under200
5Y total return	31.47%
All Time High	17.98
All Time High Change	-26.59%
All Time High Date	2025-09-08
All Time Low	0.87
All Time Low Change	1,417.24%
All Time Low Date	2022-10-31
ATR	0.6
Beta	1.4
Beta1y	1.45
Beta2y	1.16
Ch YTD	8.55
High	13.62
High52	17.98
High52 Date	2025-09-08
High52ch	-26.59%
Low	13.11
Low52	7.52
Low52 Date	2025-07-14
Low52ch	75.53%
Ma50ch	2.14%
Price vs 200-day SMA	2.1%
RSI	47.59
RSI Monthly	68.87
RSI Weekly	52.43
Sharpe ratio	0.92x
Sortino ratio	1.54
Total Return	-4.95%
Tr YTD	8.55
Tr1m	-8.78%
Tr1w	3.13%
Tr3m	19.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 627.2M
Operating Income Growth	24.39
Operating Income Growth3 Y	66.04
Operating margin	51.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	529,304,992%
Net Borrowing	99,766,115.5
Shares Insiders	7.64%
Shares Institutions	12.47%
Shares Out	835,561,162
Shares Qo Q	7.01%
Shares Yo Y	4.95%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 574.7M
Average Volume	3,171,612.2x
Bv Per Share	3.42
CAPEX	HKD -33.2M
Ch1m	-8.78
Ch1w	3.13
Ch1y	61.37
Ch3m	19.67
Ch3y	580.4
Ch5y	31.47
Ch6m	5.01
Change	-1.71%
Change From Open	-1.71
Close	13.43
Days Gap	0
Depreciation Amortization	7,956,854.8
Dollar Volume	18,216,000
Earnings Date	2026-08-27
EBIT	HKD 627.2M
EBITDA	HKD 635.1M
EPS	HKD 0.86
F Score	6
FCF	HKD 599.8M
FCF EV Yield	7.03x
FCF Per Share	HKD 0.72
Financing CF	1,224,747,634
Fiscal Year End	December
Founded	2,016
Graham Number	8.11443
Graham Upside	-38.53
Income Tax	HKD 10.3M
Investing CF	-1,393,399,212
Is Primary Listing	1
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Lynch Fair Value	HKD 21.4
Lynch Upside	62.15
Ma150	13.08
Ma150ch	0.93%
Ma20	13.83
Ma20ch	-4.57%
Net CF	467,278,820
Next Earnings Date	2026-08-27
Open	13.43
P FCF Ratio	18.39
P OCF Ratio	17.42
Position In Range	17.65
Ppne	96,570,843.1
Price Date	2026-05-08
Price EBITDA	HKD 17.37
Ptbv Ratio	3.94
Relative Volume	0.44x
Revenue	1,229,588,934x
SBC By Revenue	2.04x
Share Based Comp	25,117,161
Tax By Revenue	0.84x
Tax Rate	1.41%
Tr6m	5.01%
Volume	1,380,000
Z Score	4.56

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/2142 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/2142 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/2142?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.5%

Share of float held by funds and institutions

Insider ownership

+7.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.9%

Negative means the company is buying back shares.

Technical

HKG/2142 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.6

Neutral momentum band

Price vs 200-day MA

+2.1%

50/200-day relationship not available

Beta (5Y)

1.40

More volatile than the market

Sharpe ratio

0.92

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2142

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2142 stock rating?

hkg/2142 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2142 analysis?

The full report lives at /stocks/hkg/2142/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2142?

The latest report frames hkg/2142 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2142 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.